C&Y Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 10.3904 million yuan, a decrease of 43.17%

C&Y Pharmaceutical released its Q1 2025 performance report, with operating revenue of 182 million yuan, a year-on-year decrease of 4.09%. The net profit attributable to the parent company was 10.3904 million yuan, a year-on-year decline of 43.17%; the net profit after deducting non-recurring gains and losses was 2.7904 million yuan, a year-on-year decrease of 82.48%. The basic earnings per share were 0.043 yuan